medigraphic.com
ISSN 1405-1699 (Print)
Órgano Oficial del Colegio Mexicano de Alergia, Asma e Inmunología Pediátrica y de la Asociación Latinoamericana de Pediatría

2008, Number 1

<< Back Next >>

Alerg Asma Inmunol Pediatr 2008; 17 (1)

Common variable immunodeficiency. Focus on some active immunoprophylaxis issues

Manfredi R, Calza L

Language: Spanish
References: 13
Page: 39-42
PDF size: 194.65 Kb.


ABSTRACT

The common variable immunodeficiency, as an infrequent congenital immune system disorder, is briefly considered and discussed in the light of the existing and future active immunization options, according to the recent research and literature evidences.


REFERENCES

  1. Fischer MB, Wolf HM, Hauber I et al. Activation via the antigen receptor is impaired in T cells, but not in B cells from patients with common variable immunodeficiency. Eur J Immunol 1996; 26: 231-237.

  2. Thon V, Eggenbauer H, Wolf HM et al. Antigen presentation by common variable immunodeficiency (CVID) B cells and monocytes is unimpaired. Clin Exp Immunol 1997; 108: 1-8.

  3. Carsetti R, Rosado MM, Donnanno S et al. The loss of IgM memory B cells correlates with clinical disease in common variable immunodeficiency. J Allergy Clin Immunol 2005; 115: 412-417.

  4. MacLennan C, Dunn G, Huisson AP et al. Failure to clear persistent vaccine-derived neurovirulent Poliovirus infection in an immunodeficient man. Lancet 2004; 363: 1509-1513.

  5. Yang CF, Chen NY, Jorba J et al. Intratypic recombination among lineages of type 1 vaccine-derived Poliovirus emerging during chronic infection of an immunodeficient patient. J Virol 2005; 79: 12623-12634.

  6. Sutter RW, Prevots R. Vaccine-associated paralytic poliomyelitis among immunodeficient persons. Infect Med 1994; 11: 426-438.

  7. Centers for Disease Control and Prevention. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated Poliovirus vaccine followed by oral Poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practice (ACIP). Morbid Mortal Weekly Report 1997; 46: 1-25.

  8. Kew OM, Sutter RW, Nottay BK et al. Prolonged replication of a type 1 vaccine-derived Poliovirus in an immunodeficient patient. J Clin Microbiol 1998; 36: 2893-2899.

  9. Sewell WA. CCVID patients may not respond to Influenza immunization. Clin Immunol 2005; 114: 210.

  10. Junker AK, Bonilla FA, Sullivan KE. How to feel the flu. Clin Immunol 2004; 112: 219-220.

  11. Edwards E, Razvi S, Cunningham-Rundles C. IgA deficiency: clinical correlates and responses to pneumococcal vaccine. Clin Immunol 2004; 111: 93-97.

  12. Avanzini MA, Bjorkander J, Soderstrom R et al. Qualitative and quantitative analyses of the antibody response elicited by Haemophilus influenzae type B capsular polysaecharide-tetanus toxoid conjugates in adults in IgG subclass deficiencies and frequent infections. Clin Exp Immunol 1994; 96: 54-58.

  13. Barra A, Bremard-Oury C, Bajart A, Griscelli C, Fritzell B, Preud’homme JL. Immunogenicity of Haemophilus influenzae type N capsular polysaccharide and its tetanus toxoid conjugate in patients with recurrent infections or humoral immunodeficiency. Int J Clin Lab Res 1992; 21: 231-234.




2020     |     www.medigraphic.com